For research use only
| Cat No. | ABC-TC4351 |
| Product Type | Diseased Human Peripheral Blood Mononuclear Cells |
| Cell Type | Mononuclear Cell |
| Species | Human |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Peripheral Blood |
| Disease | Pediatric |
| Storage | Liquid Nitrogen |
Human Pediatric PBMCs support immune system studies via T-cell, B-cell, NK-cell, and monocyte functions in pediatric immunity and disease modeling.
Human Pediatric Peripheral Blood Mononuclear Cells (PBMCs) are isolated from the peripheral blood of pediatric donors, capturing the dynamic immune profiles of developing immune systems across childhood. These human-derived PBMCs contain developmentally distinct populations of lymphocytes (naive T cells, B cells, NK cells) and monocytes that exhibit age-specific immune characteristics, including higher proportions of naive T cells (CD45RA⁺) and enhanced innate immune responses compared to adult counterparts. The cells display typical mononuclear morphology with intact surface markers and maintain robust functional responses to stimuli. They are particularly valuable for studying immune ontogeny, vaccine responses, and pediatric-specific diseases, as children’s immune systems differ significantly from adults in both composition and function. Moreover, these mononuclear cells provide an essential experimental platform for investigating age-dependent immune regulation and developmental differences in immune signaling pathways under physiological and pathological conditions.
| Product Code | Human Pediatric Peripheral Blood Mononuclear Cells, hPediatric-PBMC, PBMCs from Pediatric Donors |
| Species | Human |
| Cat.No | ABC-TC4351 |
| Product Category | Primary Cells |
| Size/Quantity | 1 vial |
| Cell Type | Mononuclear Cell |
| Growth Mode | Adherent |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Peripheral Blood |
| Disease | Pediatric |
| Storage | Liquid Nitrogen |
| Product Type | Diseased Human Peripheral Blood Mononuclear Cells |
| Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
Human Pediatric PBMCs enable researchers to investigate age-specific immune responses to vaccines and infections, study developmental immunology, and understand pediatric disease pathogenesis. Scientists utilize these cells to develop age-appropriate immunotherapies, characterize immune maturation processes, and establish reference ranges for pediatric immune parameters. The PBMCs also support research into childhood autoimmune disorders, primary immunodeficiencies, and cancer immunotherapy approaches tailored for pediatric patients.
When you publish your research, please cite our product as "AcceGen Biotech Cat.# XXX-0000". In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).